Shareholder Alert: Ademi LLP investigates whether Acer Therapeutics Inc. has obtained a Fair Price in its transaction with Zevra

MILWAUKEE, Aug. 31, 2023 /PRNewswire/ — Ademi LLP is investigating Acer (Nasdaq: ACER) for possible breaches of fiduciary duty and other violations of law in its transaction with Zevra. Click here to learn how to join the action https://www.ademilaw.com/case/acer-therapeutics-inc or call…